Ridgetech Inc.

RDGT Healthcare Pharmaceutical Retailers

Ridgetech Inc.’s revenue for fiscal 2026 (year ended March 2026) was $132.2 million, up 10.2% from fiscal 2025.

1.00 0.25 +33.33%
Market cap
$2.7M
P/E
0.0×
Fwd P/E
−5.6×
Dividend yield
—
F-score
4/9
Altman Z
1.16
Beneish M
−2.32
Dividend safety
n/a

Ridgetech Inc. (RDGT) EV/Sales

Alert me on EV/Sales

As of 6 November 2026, Ridgetech Inc. (RDGT) trades at a EV/Sales of 0.0×. Over the past ten years it has ranged from −0.1× (March 2022) to 99.4× (January 2015); the current reading is higher than 35% of that period. That is below the Healthcare sector median of 3.6×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2026 0.0× —
FY2025 −0.1× —
FY2024 −0.1× —
FY2023 0.0× —
FY2022 −0.1× —
FY2021 0.2× (35.04%)
FY2020 0.3× (45.92%)
FY2019 0.5× 3,097.60%
FY2018 0.0× (87.86%)
FY2017 0.1× 417.29%

Quarterly newest first

Period EV/Sales Change
Mar 2023 454× 364.37%
Sep 2022 97.8× 587.07%
Mar 2022 14.2× (96.79%)
Sep 2021 444× 236,444.62%
25 more quarters

Against its own ten years

Low −0.1× High 99.4×
Ten-year median 0.1×
Current reading's percentile 35

EV/Sales against peers

Company EV/Sales
RDGT Ridgetech Inc. 0.0×
POM Pomdoctor Limited - Sponsored ADR compare n/m
PETS PetMed Express, Inc. compare 0.1×
HITI High Tide Inc. compare 0.5×
SCNX Scienture Holdings, Inc. compare 8.4×
Healthcare sector median 3.6×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on RDGT